Myconic Capital Corp.
Private Equity Group
Myconic Capital Corp., formerly known as Auralite Investments Inc., is a Canadian company focused on the acquisition and introduction of ketamine treatments for military, RCMP, and first responder patients. Operating primarily in the healthcare sector, the company aims to expand its services through new clinics and innovative therapies, including psychedelic-assisted treatments, subject to regulatory exemptions. Myconic Capital Corp. is publicly traded on the Canadian Securities Exchange (CSE) under the ticker MEDI.
Recent Transactions involving Myconic Capital Corp.
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Myconic Enters Into LOI to Acquire and Introduce Ketamine Treatments to Canada’s First and Only Multidisciplinary Physical Therapy Clinic Exclusively for Military, RCMP, and First Responder Patients |
Integrated Rehab and Performance |
Myconic Capital Corp. |
Sports Medicine |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →